Una revisión sistemática y meta-análisis de la eficacia y seguridad de adalimumab en el tratamiento de la artritis reumatoide

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2011
Cargando información sobre las referencias

CRD SUMMARY:

This generally well-conducted review concluded that adalimumab was more effective than placebo for patients with rheumatoid arthritis, but that adverse events need careful attention. The authors' conclusions appear appropriate, but the longer term results were based on only two trials, one of which had a markedly different patient group, so this analysis may be less reliable.
Epistemonikos ID: befa8b096797355db2523ae86f9d16a149a028ab
First added on: Jun 08, 2012